The GW pharmaceuticals are the best development and commercialization in the field. However, the novel therapeutics products are a pharmaceutical formulation of cannabinoid. Mainly focus on the best treatment of seizures associated with tuberous sclerosis complex. provides focused on developing the best platform in the high range of disease areas. In years of experience, it established leading positions in the commercialization of plant-derived cannabinoids. Most importantly, it also has proven drug discovery and intellectual property, regulatory, manufacturing and commercial expertise. Now, they lead to cannabinoid product is Epidiolex as well as the formulation of CBD in the commercial rights. It also approved to use treatment of seizures across the world.